Filter your results
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Sonidegib improved quality of life in patients with advanced basal cell carcinoma: results from the phase 2 Basal Cell Carcinoma Outcomes with LDE225 Treatment trial through 73 weeksJournal of The American Academy of Dermatology, 2022, Online ahead of print. ⟨10.1016/j.jdin.2022.08.027⟩
Journal articles
inserm-03818996v1
|